Chronic obstructive pulmonary disease is a heterogeneous disease caused by the interaction …

• Abstract
• Background
• References
• Figures
• Tables

Biology Articles » Genetics » Clinical Genetics » The genetics of chronic obstructive pulmonary disease » References

References

- The genetics of chronic obstructive pulmonary disease

1.   Celli BR, MacNee W: Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper.Eur Respir J 2004, 23(6):932-946.         2.   ATS: Chronic bronchitis, asthma and pulmonary emphysema: a statement by the committee on diagnostic standards for non-tuberculous respiratory diseases.Am Rev Resp Dis 1962, 85:762-768.         3.   Snider GL, Kleineman J, Thurlbeck WM, Bengali ZK: The definition of emphysema: a report of the National Heart, Lung and Blood Institute, Division of Lung Diseases Workshop.Am Rev Resp Dis 1985, 132:182-185.         4.   Agusti AG: Systemic effects of chronic obstructive pulmonary disease.Proc Am Thorac Soc 2005, 2(4):367-70; discussion 371-2.         5.   ATS: Cigarette smoking and health. Am J Respir Crit Care Med 1996, 153(2):861-865.         6.   Burrows B, Knudson RJ, Cline MG, Lebowitz MD: Quantitative relationship between cigarette smoking and ventilatory function.Am Rev Resp Dis 1977, 115:195-205.         7.   Coultas DB, Hanis CL, Howard CA, Skipper BJ, Samet JM: Heritability of ventilatory function in smoking and nonsmoking New Mexico Hispanics.Am Rev Respir Dis 1991, 144(4):770-775.         8.   Redline S, Tishler PV, Rosner B, Lewitter FI, Vandenburgh M, Weiss ST, Speizer FE: Genotypic and phenotypic similarities in pulmonary function among family members of adult monozygotic and dizygotic twins.Am J Epidemiol 1989, 129(4):827-836.         9.   Lewitter FI, Tager IB, McGue M, Tishler PV, Speizer FE: Genetic and environmental determinants of level of pulmonary function.Am J Epidemiol 1984, 120(4):518-530.         10.   Kueppers F, Miller RD, Gordon H, Hepper NG, Offord K: Familial prevalence of chronic obstructive pulmonary disease in a matched pair study.Am J Med 1977, 63(3):336-342.         11.   Fletcher C, Peto R: The natural history of chronic airflow obstruction.Br Med J 1977, 1(6077):1645-1648.         12.   Hartl DG, Clark AG: Priniciples of population genetics.Sunderland, MA , Sinauer Associates; 1997.         13.   Cordell HJ: Epistasis: what it means, what it doesn't mean, and statistical methods to detect it in humans.Hum Mol Genet 2002, 11(20):2463-2468.         14.   Baierl A, Bogdan M, Frommlet F, Futschik A: On locating multiple interacting quantitative trait loci in intercross designs.Genetics 2006, 173(3):1693-1703.          15.   Stockley RA: Neutrophils and protease/antiprotease imbalance.Am J Respir Crit Care Med 1999, 160(5 Pt 2):S49-52.         16.   Shapiro SD, Senior RM: Matrix metalloproteinases. Matrix degradation and more.Am J Respir Cell Mol Biol 1999, 20(6):1100-1102.         17.   Eriksson SS: Studies in alpha 1 antitrypsin deficiency.Acta MedScand 1965, 177 (Suppl.):432.         18.   Sloan B, Abrams WR, Meranze DR, Kimbel P, Weinbaum G: Emphysema induced in vitro and in vivo in dogs by a purified elastase from homologous leukocytes.Am Rev Respir Dis 1981, 124(3):295-301.         19.   Foronjy R, D'Armiento J: The role of collagenase in emphysema.Respir Res 2001, 2(6):348-352.         20.   MacNee W: Oxidants/antioxidants and COPD.Chest 2000, 117(5 Suppl 1):303S-17S.         21.   O'Donnell R, Breen D, Wilson S, Djukanovic R: Inflammatory cells in the airways in COPD.Thorax 2006, 61(5):448-454.         22.   Strachan T, Read AP: Human Molecular Genetics.Oxford , Garland Science Publishers; 2003.         23.   Wang DG, Fan JB, Siao CJ, Berno A, Young P, Sapolsky R, Ghandour G, Perkins N, Winchester E, Spencer J, Kruglyak L, Stein L, Hsie L, Topaloglou T, Hubbell E, Robinson E, Mittmann M, Morris MS, Shen N, Kilburn D, Rioux J, Nusbaum C, Rozen S, Hudson TJ, Lipshutz R, Chee M, Lander ES: Large-scale identification, mapping, and genotyping of single-nucleotide polymorphisms in the human genome.Science 1998, 280(5366):1077-1082.         24.   Carlson CS, Eberle MA, Kruglyak L, Nickerson DA: Mapping complex disease loci in whole-genome association studies.Nature 2004, 429(6990):446-452.         25.   Sachidanandam R, Weissman D, Schmidt SC, Kakol JM, Stein LD, Marth G, Sherry S, Mullikin JC, Mortimore BJ, Willey DL, Hunt SE, Cole CG, Coggill PC, Rice CM, Ning Z, Rogers J, Bentley DR, Kwok PY, Mardis ER, Yeh RT, Schultz B, Cook L, Davenport R, Dante M, Fulton L, Hillier L, Waterston RH, McPherson JD, Gilman B, Schaffner S, Van Etten WJ, Reich D, Higgins J, Daly MJ, Blumenstiel B, Baldwin J, Stange-Thomann N, Zody MC, Linton L, Lander ES, Altshuler D: A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms.Nature 2001, 409(6822):928-933.         26.   The International HapMap Consortium: A Haplotype Map of the Human Genome.Nature 2005, 437:1299-1320.         27.   HapMap [http://www.hapmap.org/]         28.   Hersh CP, Demeo DL, Lange C, Litonjua AA, Reilly JJ, Kwiatkowski D, Laird N, Sylvia JS, Sparrow D, Speizer FE, Weiss ST, Silverman EK: Attempted replication of reported chronic obstructive pulmonary disease candidate gene associations.Am J Respir Cell Mol Biol 2005, 33(1):71-78.         29.   Risch NJ: Searching for genetic determinants in the new millennium.Nature 2000, 405(6788):847-856.         30.   Thompson EA: Linkage analysis.In Handbook of statistical Genetics. Edited by: Balding DJ, Bishop M, Cannings C. Chichester , Wiley; 2001.         31.   Toivonen HT, Onkamo P, Vasko K, Ollikainen V, Sevon P, Mannila H, Herr M, Kere J: Data mining applied to linkage disequilibrium mapping.Am J Hum Genet 2000, 67(1):133-145.         32.   Mira MT, Alcais A, Nguyen VT, Moraes MO, Di Flumeri C, Vu HT, Mai CP, Nguyen TH, Nguyen NB, Pham XK, Sarno EN, Alter A, Montpetit A, Moraes ME, Moraes JR, Dore C, Gallant CJ, Lepage P, Verner A, Van De Vosse E, Hudson TJ, Abel L, Schurr E: Susceptibility to leprosy is associated with PARK2 and PACRG.Nature 2004, 427(6975):636-640.         33.   Morton NE: Sequential tests for the detection of linkage.Am J Hum Genet 1955, 7(3):277-318.         34.   Lander E, Kruglyak L: Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results.Nat Genet 1995, 11(3):241-247.         35.   Demeo DL, Mariani TJ, Lange C, Srisuma S, Litonjua AA, Celedon JC, Lake SL, Reilly JJ, Chapman HA, Mecham BH, Haley KJ, Sylvia JS, Sparrow D, Spira AE, Beane J, Pinto-Plata V, Speizer FE, Shapiro SD, Weiss ST, Silverman EK: The SERPINE2 Gene Is Associated with Chronic Obstructive Pulmonary Disease.Am J Hum Genet 2006, 78(2):253-264.         36.   Palmer LJ, Celedon JC, Chapman HA, Speizer FE, Weiss ST, Silverman EK: Genome-wide linkage analysis of bronchodilator responsiveness and post-bronchodilator spirometric phenotypes in chronic obstructive pulmonary disease.Hum Mol Genet 2003, 12(10):1199-1210.         37.   Silverman EK, Mosley JD, Palmer LJ, Barth M, Senter JM, Brown A, Drazen JM, Kwiatkowski DJ, Chapman HA, Campbell EJ, Province MA, Rao DC, Reilly JJ, Ginns LC, Speizer FE, Weiss ST: Genome-wide linkage analysis of severe, early-onset chronic obstructive pulmonary disease: airflow obstruction and chronic bronchitis phenotypes.Hum Mol Genet 2002, 11(6):623-632.         38.   Silverman EK, Palmer LJ, Mosley JD, Barth M, Senter JM, Brown A, Drazen JM, Kwiatkowski DJ, Chapman HA, Campbell EJ, Province MA, Rao DC, Reilly JJ, Ginns LC, Speizer FE, Weiss ST: Genomewide linkage analysis of quantitative spirometric phenotypes in severe early-onset chronic obstructive pulmonary disease.Am J Hum Genet 2002, 70(5):1229-1239.         39.   DeMeo DL, Celedon JC, Lange C, Reilly JJ, Chapman HA, Sylvia JS, Speizer FE, Weiss ST, Silverman EK: Genome-wide linkage of forced mid-expiratory flow in chronic obstructive pulmonary disease.Am J Respir Crit Care Med 2004, 170(12):1294-1301.         40.   Beeh KM, Kornmann O, Buhl R, Culpitt SV, Giembycz MA, Barnes PJ: Neutrophil chemotactic activity of sputum from patients with COPD: role of interleukin 8 and leukotriene B4.Chest 2003, 123(4):1240-1247.         41.   Barnes PJ, Shapiro SD, Pauwels RA: Chronic obstructive pulmonary disease: molecular and cellular mechanisms.Eur Respir J 2003, 22(4):672-688.         42.   Dery O, Corvera CU, Steinhoff M, Bunnett NW: Proteinase-activated receptors: novel mechanisms of signaling by serine proteases.Am J Physiol 1998, 274(6 Pt 1):C1429-52.         43.   Fagerhol MK, Laurell CB: The Pi system-inherited variants of serum alpha 1-antitrypsin.Prog Med Genet 1970, 7:96-111.         44.   Luisetti M, Seersholm N: Alpha1-antitrypsin deficiency. 1: epidemiology of alpha1-antitrypsin deficiency.Thorax 2004, 59(2):164-169.         45.   Needham M, Stockley RA: Alpha 1-antitrypsin deficiency. 3: Clinical manifestations and natural history.Thorax 2004, 59(5):441-445.         46.   DeMeo DL, Silverman EK: Alpha1-antitrypsin deficiency. 2: genetic aspects of alpha(1)-antitrypsin deficiency: phenotypes and genetic modifiers of emphysema risk.Thorax 2004, 59(3):259-264.         47.   Chappell S, Daly L, Morgan K, Guetta Baranes T, Roca J, Rabinovich R, Millar A, Donnelly SC, Keatings V, MacNee W, Stolk J, Hiemstra P, Miniati M, Monti S, O'Connor CM, Kalsheker N: Cryptic haplotypes of SERPINA1 confer susceptibility to chronic obstructive pulmonary disease.Hum Mutat 2006, 27(1):103-109.         48.   Silverman EK, Province MA, Campbell EJ, Pierce JA, Rao DC: Variability of pulmonary function in alpha-1-antitrypsin deficiency: residual family resemblance beyond the effect of the Pi locus.Hum Hered 1990, 40(6):340-355.         49.   Novoradovsky A, Brantly ML, Waclawiw MA, Chaudhary PP, Ihara H, Qi L, Eissa NT, Barnes PM, Gabriele KM, Ehrmantraut ME, Rogliani P, Moss J: Endothelial nitric oxide synthase as a potential susceptibility gene in the pathogenesis of emphysema in alpha1-antitrypsin deficiency.Am J Respir Cell Mol Biol 1999, 20(3):441-447.         50.   Hart CM: Nitric oxide in adult lung disease.Chest 1999, 115(5):1407-1417.         51.   D'Armiento J, Dalal SS, Okada Y, Berg RA, Chada K: Collagenase expression in the lungs of transgenic mice causes pulmonary emphysema.Cell 1992, 71(6):955-961.         52.   Hautamaki RD, Kobayashi DK, Senior RM, Shapiro SD: Requirement for macrophage elastase for cigarette smoke-induced emphysema in mice.Science 1997, 277(5334):2002-2004.         53.   Finlay GA, Russell KJ, McMahon KJ, D'Arcy E M, Masterson JB, FitzGerald MX, O'Connor CM: Elevated levels of matrix metalloproteinases in bronchoalveolar lavage fluid of emphysematous patients.Thorax 1997, 52(6):502-506.         54.   Zhang B, Ye S, Herrmann SM, Eriksson P, de Maat M, Evans A, Arveiler D, Luc G, Cambien F, Hamsten A, Watkins H, Henney AM: Functional polymorphism in the regulatory region of gelatinase B gene in relation to severity of coronary atherosclerosis.Circulation 1999, 99(14):1788-1794.         55.   Zhou M, Huang SG, Wan HY, Li B, Deng WW, Li M: Genetic polymorphism in matrix metalloproteinase-9 and the susceptibility to chronic obstructive pulmonary disease in Han population of south China.Chin Med J (Engl) 2004, 117(10):1481-1484.         56.   Minematsu N, Nakamura H, Tateno H, Nakajima T, Yamaguchi K: Genetic polymorphism in matrix metalloproteinase-9 and pulmonary emphysema.Biochem Biophys Res Commun 2001, 289(1):116-119.         57.   Ito I, Nagai S, Handa T, Muro S, Hirai T, Tsukino M, Mishima M: Matrix metalloproteinase-9 promoter polymorphism associated with upper lung dominant emphysema.Am J Respir Crit Care Med 2005, 172(11):1378-1382.         58.   Rutter JL, Mitchell TI, Buttice G, Meyers J, Gusella JF, Ozelius LJ, Brinckerhoff CE: A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter creates an Ets binding site and augments transcription.Cancer Res 1998, 58(23):5321-5325.         59.   Joos L, He JQ, Shepherdson MB, Connett JE, Anthonisen NR, Pare PD, Sandford AJ: The role of matrix metalloproteinase polymorphisms in the rate of decline in lung function.Hum Mol Genet 2002, 11(5):569-576.         60.   Howard EW, Bullen EC, Banda MJ: Preferential inhibition of 72- and 92-kDa gelatinases by tissue inhibitor of metalloproteinases-2.J Biol Chem 1991, 266(20):13070-13075.         61.   Ohnishi K, Takagi M, Kurokawa Y, Satomi S, Konttinen YT: Matrix metalloproteinase-mediated extracellular matrix protein degradation in human pulmonary emphysema.Lab Invest 1998, 78(9):1077-1087.         62.   Hirano K, Sakamoto T, Uchida Y, Morishima Y, Masuyama K, Ishii Y, Nomura A, Ohtsuka M, Sekizawa K: Tissue inhibitor of metalloproteinases-2 gene polymorphisms in chronic obstructive pulmonary disease.Eur Respir J 2001, 18(5):748-752.         63.   Poller W, Faber JP, Scholz S, Weidinger S, Bartholome K, Olek K, Eriksson S: Mis-sense mutation of alpha 1-antichymotrypsin gene associated with chronic lung disease.Lancet 1992, 339(8808):1538.         64.   Poller W, Faber JP, Weidinger S, Tief K, Scholz S, Fischer M, Olek K, Kirchgesser M, Heidtmann HH: A leucine-to-proline substitution causes a defective alpha 1-antichymotrypsin allele associated with familial obstructive lung disease.Genomics 1993, 17(3):740-743.         65.   Ishii T, Matsuse T, Teramoto S, Matsui H, Hosoi T, Fukuchi Y, Ouchi Y: Association between alpha-1-antichymotrypsin polymorphism and susceptibility to chronic obstructive pulmonary disease.Eur J Clin Invest 2000, 30(6):543-548.         66.   Benetazzo MG, Gile LS, Bombieri C, Malerba G, Massobrio M, Pignatti PF, Luisetti M: alpha 1-antitrypsin TAQ I polymorphism and alpha 1-antichymotrypsin mutations in patients with obstructive pulmonary disease.Respir Med 1999, 93(9):648-654.         67.   Hunninghake GW, Crystal RG: Cigarette smoking and lung destruction. Accumulation of neutrophils in the lungs of cigarette smokers.Am Rev Respir Dis 1983, 128(5):833-838.         68.   Young RP, Hopkins R, Black PN, Eddy C, Wu L, Gamble GD, Mills GD, Garrett JE, Eaton TE, Rees MI: Functional variants of antioxidant genes in smokers with COPD and in those with normal lung function.Thorax 2006, 61(5):394-399.         69.   Mannervik B: The isoenzymes of glutathione transferase.Adv Enzymol Relat Areas Mol Biol 1985, 57:357-417.         70.   He JQ, Ruan J, Connett JE, Anthonisen NR, Pare PD, Sandford AJ: Antioxidant gene polymorphisms and susceptibility to a rapid decline in lung function in smokers.Am J Respir Crit Care Med 2002, 166(3):323-328.         71.   Ishii T, Matsuse T, Teramoto S, Matsui H, Miyao M, Hosoi T, Takahashi H, Fukuchi Y, Ouchi Y: Glutathione S-transferase P1 (GSTP1) polymorphism in patients with chronic obstructive pulmonary disease.Thorax 1999, 54(8):693-696.         72.   He JQ, Connett JE, Anthonisen NR, Pare PD, Sandford AJ: Glutathione S-transferase variants and their interaction with smoking on lung function.Am J Respir Crit Care Med 2004, 170(4):388-394.         73.   Ali-Osman F, Akande O, Antoun G, Mao JX, Buolamwini J: Molecular cloning, characterization, and expression in Escherichia coli of full-length cDNAs of three human glutathione S-transferase Pi gene variants. Evidence for differential catalytic activity of the encoded proteins.J Biol Chem 1997, 272(15):10004-10012.         74.   Sundberg K, Johansson AS, Stenberg G, Widersten M, Seidel A, Mannervik B, Jernstrom B: Differences in the catalytic efficiencies of allelic variants of glutathione transferase P1-1 towards carcinogenic diol epoxides of polycyclic aromatic hydrocarbons.Carcinogenesis 1998, 19(3):433-436.         75.   Gilliland FD, Gauderman WJ, Vora H, Rappaport E, Dubeau L: Effects of glutathione-S-transferase M1, T1, and P1 on childhood lung function growth.Am J Respir Crit Care Med 2002, 166(5):710-716.         76.   Harrison DJ, Cantlay AM, Rae F, Lamb D, Smith CA: Frequency of glutathione S-transferase M1 deletion in smokers with emphysema and lung cancer.Hum Exp Toxicol 1997, 16(7):356-360.         77.   Baranova H, Perriot J, Albuisson E, Ivaschenko T, Baranov VS, Hemery B, Mouraire P, Riol N, Malet P: Peculiarities of the GSTM1 0/0 genotype in French heavy smokers with various types of chronic bronchitis.Hum Genet 1997, 99(6):822-826.         78.   Ryberg D, Skaug V, Hewer A, Phillips DH, Harries LW, Wolf CR, Ogreid D, Ulvik A, Vu P, Haugen A: Genotypes of glutathione transferase M1 and P1 and their significance for lung DNA adduct levels and cancer risk.Carcinogenesis 1997, 18(7):1285-1289.         79.   Yim JJ, Park GY, Lee CT, Kim YW, Han SK, Shim YS, Yoo CG: Genetic susceptibility to chronic obstructive pulmonary disease in Koreans: combined analysis of polymorphic genotypes for microsomal epoxide hydrolase and glutathione S-transferase M1 and T1.Thorax 2000, 55(2):121-125.         80.   Oury TD, Chang LY, Marklund SL, Day BJ, Crapo JD: Immunocytochemical localization of extracellular superoxide dismutase in human lung.Lab Invest 1994, 70(6):889-898.         81.   Folz RJ, Abushamaa AM, Suliman HB: Extracellular superoxide dismutase in the airways of transgenic mice reduces inflammation and attenuates lung toxicity following hyperoxia.J Clin Invest 1999, 103(7):1055-1066.         82.   Bowler RP, Nicks M, Tran K, Tanner G, Chang LY, Young SK, Worthen GS: Extracellular superoxide dismutase attenuates lipopolysaccharide-induced neutrophilic inflammation.Am J Respir Cell Mol Biol 2004, 31(4):432-439.         83.   Juul K, Tybjaerg-Hansen A, Marklund S, Lange P, Nordestgaard BG: Genetically increased antioxidative protection and decreased chronic obstructive pulmonary disease.Am J Respir Crit Care Med 2006, 173(8):858-864.         84.   Bartsch H, Petruzzelli S, De Flora S, Hietanen E, Camus AM, Castegnaro M, Alexandrov K, Rojas M, Saracci R, Giuntini C: Carcinogen metabolism in human lung tissues and the effect of tobacco smoking: results from a case--control multicenter study on lung cancer patients.Environ Health Perspect 1992, 98:119-124.         85.   Tingle MD, Pirmohamed M, Templeton E, Wilson AS, Madden S, Kitteringham NR, Park BK: An investigation of the formation of cytotoxic, genotoxic, protein-reactive and stable metabolites from naphthalene by human liver microsomes.Biochem Pharmacol 1993, 46(9):1529-1538.         86.   Hassett C, Aicher L, Sidhu JS, Omiecinski CJ: Human microsomal epoxide hydrolase: genetic polymorphism and functional expression in vitro of amino acid variants.Hum Mol Genet 1994, 3(3):421-428.         87.   Hosagrahara VP, Rettie AE, Hassett C, Omiecinski CJ: Functional analysis of human microsomal epoxide hydrolase genetic variants.Chem Biol Interact 2004, 150(2):149-159.         88.   Raaka S, Hassett C, Omiencinski CJ: Human microsomal epoxide hydrolase: 5'-flanking region genetic polymorphisms.Carcinogenesis 1998, 19(3):387-393.         89.   Smith CA, Harrison DJ: Association between polymorphism in gene for microsomal epoxide hydrolase and susceptibility to emphysema.Lancet 1997, 350(9078):630-633.         90.   Yoshikawa M, Hiyama K, Ishioka S, Maeda H, Maeda A, Yamakido M: Microsomal epoxide hydrolase genotypes and chronic obstructive pulmonary disease in Japanese.Int J Mol Med 2000, 5(1):49-53.         91.   Sandford AJ, Chagani T, Weir TD, Connett JE, Anthonisen NR, Pare PD: Susceptibility genes for rapid decline of lung function in the lung health study.Am J Respir Crit Care Med 2001, 163(2):469-473.         92.   Hersh CP, Demeo DL, Lazarus R, Celedon JC, Raby BA, Benditt JO, Criner G, Make B, Martinez FJ, Scanlon PD, Sciurba FC, Utz JP, Reilly JJ, Silverman EK: Genetic association analysis of functional impairment in chronic obstructive pulmonary disease.Am J Respir Crit Care Med 2006, 173(9):977-984.         93.   Tenhunen R, Marver HS, Schmid R: The enzymatic conversion of heme to bilirubin by microsomal heme oxygenase.Proc Natl Acad Sci U S A 1968, 61(2):748-755.         94.   Maestrelli P, El Messlemani AH, De Fina O, Nowicki Y, Saetta M, Mapp C, Fabbri LM: Increased expression of heme oxygenase (HO)-1 in alveolar spaces and HO-2 in alveolar walls of smokers.Am J Respir Crit Care Med 2001, 164(8 Pt 1):1508-1513.         95.   Okinaga S, Takahashi K, Takeda K, Yoshizawa M, Fujita H, Sasaki H, Shibahara S: Regulation of human heme oxygenase-1 gene expression under thermal stress.Blood 1996, 87(12):5074-5084.         96.   Yamada N, Yamaya M, Okinaga S, Nakayama K, Sekizawa K, Shibahara S, Sasaki H: Microsatellite polymorphism in the heme oxygenase-1 gene promoter is associated with susceptibility to emphysema.Am J Hum Genet 2000, 66(1):187-195.         97.   Guenegou A, Leynaert B, Benessiano J, Pin I, Demoly P, Neukirch F, Boczkowski J, Aubier M: Association of lung function decline with the heme oxygenase-1 gene promoter microsatellite polymorphism in a general population sample. Results from the European Community Respiratory Health Survey (ECRHS), France.J Med Genet 2006, 43(8):e43.         98.   Sevenoaks MJ, Stockley RA: Chronic Obstructive Pulmonary Disease, inflammation and co-morbidity--a common inflammatory phenotype?Respir Res 2006, 7:70.         99.   Wouters EF: Local and systemic inflammation in chronic obstructive pulmonary disease.Proc Am Thorac Soc 2005, 2(1):26-33.         100.   Churg A, Wang RD, Tai H, Wang X, Xie C, Wright JL: Tumor necrosis factor-alpha drives 70% of cigarette smoke-induced emphysema in the mouse.Am J Respir Crit Care Med 2004, 170(5):492-498.         101.   Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW: Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation.Proc Natl Acad Sci U S A 1997, 94(7):3195-3199.         102.   Huang SL, Su CH, Chang SC: Tumor necrosis factor-alpha gene polymorphism in chronic bronchitis.Am J Respir Crit Care Med 1997, 156(5):1436-1439.         103.   Sakao S, Tatsumi K, Igari H, Shino Y, Shirasawa H, Kuriyama T: Association of tumor necrosis factor alpha gene promoter polymorphism with the presence of chronic obstructive pulmonary disease.Am J Respir Crit Care Med 2001, 163(2):420-422.         104.   Sakao S, Tatsumi K, Igari H, Watanabe R, Shino Y, Shirasawa H, Kuriyama T: Association of tumor necrosis factor-alpha gene promoter polymorphism with low attenuation areas on high-resolution CT in patients with COPD.Chest 2002, 122(2):416-420.         105.   Wilson AG, de Vries N, Pociot F, di Giovine FS, van der Putte LB, Duff GW: An allelic polymorphism within the human tumor necrosis factor alpha promoter region is strongly associated with HLA A1, B8, and DR3 alleles.J Exp Med 1993, 177(2):557-560.         106.   Blobe GC, Schiemann WP, Lodish HF: Role of transforming growth factor beta in human disease.N Engl J Med 2000, 342(18):1350-1358.         107.   Morris DG, Huang X, Kaminski N, Wang Y, Shapiro SD, Dolganov G, Glick A, Sheppard D: Loss of integrin alpha(v)beta6-mediated TGF-beta activation causes Mmp12-dependent emphysema.Nature 2003, 422(6928):169-173.         108.   Celedon JC, Lange C, Raby BA, Litonjua AA, Palmer LJ, DeMeo DL, Reilly JJ, Kwiatkowski DJ, Chapman HA, Laird N, Sylvia JS, Hernandez M, Speizer FE, Weiss ST, Silverman EK: The transforming growth factor-beta1 (TGFB1) gene is associated with chronic obstructive pulmonary disease (COPD).Hum Mol Genet 2004, 13(15):1649-1656.         109.   Grainger DJ, Heathcote K, Chiano M, Snieder H, Kemp PR, Metcalfe JC, Carter ND, Spector TD: Genetic control of the circulating concentration of transforming growth factor type beta1.Hum Mol Genet 1999, 8(1):93-97.         110.   Suthanthiran M, Li B, Song JO, Ding R, Sharma VK, Schwartz JE, August P: Transforming growth factor-beta 1 hyperexpression in African-American hypertensives: A novel mediator of hypertension and/or target organ damage.Proc Natl Acad Sci U S A 2000, 97(7):3479-3484.         111.   Yamamoto N, Homma S: Vitamin D3 binding protein (group-specific component) is a precursor for the macrophage-activating signal factor from lysophosphatidylcholine-treated lymphocytes.Proc Natl Acad Sci U S A 1991, 88(19):8539-8543.         112.   Kew RR, Webster RO: Gc-globulin (vitamin D-binding protein) enhances the neutrophil chemotactic activity of C5a and C5a des Arg.J Clin Invest 1988, 82(1):364-369.         113.   DiMartino SJ, Shah AB, Trujillo G, Kew RR: Elastase controls the binding of the vitamin D-binding protein (Gc-globulin) to neutrophils: a potential role in the regulation of C5a co-chemotactic activity.J Immunol 2001, 166(4):2688-2694.         114.   Schellenberg D, Pare PD, Weir TD, Spinelli JJ, Walker BA, Sandford AJ: Vitamin D binding protein variants and the risk of COPD.Am J Respir Crit Care Med 1998, 157(3 Pt 1):957-961.         115.   Horne SL, Cockcroft DW, Dosman JA: Possible protective effect against chronic obstructive airways disease by the GC2 allele.Hum Hered 1990, 40(3):173-176.         116.   Viau M, Constans J, Debray H, Montreuil J: Isolation and characterization of the O-glycan chain of the human vitamin-D binding protein.Biochem Biophys Res Commun 1983, 117(1):324-331.         117.   Ito I, Nagai S, Hoshino Y, Muro S, Hirai T, Tsukino M, Mishima M: Risk and severity of COPD is associated with the group-specific component of serum globulin 1F allele.Chest 2004, 125(1):63-70.         118.   Ishii T, Keicho N, Teramoto S, Azuma A, Kudoh S, Fukuchi Y, Ouchi Y, Matsuse T: Association of Gc-globulin variation with susceptibility to COPD and diffuse panbronchiolitis.Eur Respir J 2001, 18(5):753-757.         119.   Zheng T, Zhu Z, Wang Z, Homer RJ, Ma B, Riese RJ Jr., Chapman HA Jr., Shapiro SD, Elias JA: Inducible targeting of IL-13 to the adult lung causes matrix metalloproteinase- and cathepsin-dependent emphysema.J Clin Invest 2000, 106(9):1081-1093.         120.   van der Pouw Kraan TC, van Veen A, Boeije LC, van Tuyl SA, de Groot ER, Stapel SO, Bakker A, Verweij CL, Aarden LA, van der Zee JS: An IL-13 promoter polymorphism associated with increased risk of allergic asthma.Genes Immun 1999, 1(1):61-65.         121.   van der Pouw Kraan TC, Kucukaycan M, Bakker AM, Baggen JM, van der Zee JS, Dentener MA, Wouters EF, Verweij CL: Chronic obstructive pulmonary disease is associated with the -1055 IL-13 promoter polymorphism.Genes Immun 2002, 3(7):436-439.         122.   Ingenito EP, Tsai LW, Majumdar A, Suki B: On the role of surface tension in the pathophysiology of emphysema.Am J Respir Crit Care Med 2005, 171(4):300-304.         123.   Guo X, Lin HM, Lin Z, Montano M, Sansores R, Wang G, DiAngelo S, Pardo A, Selman M, Floros J: Surfactant protein gene A, B, and D marker alleles in chronic obstructive pulmonary disease of a Mexican population.Eur Respir J 2001, 18(3):482-490.         124.   Chappell S, Daly L, Morgan K, Baranes TG, Roca J, Rabinovich R, Millar A, Donnelly SC, Keatings V, MacNee W, Stolk J, Hiemstra PS, Miniati M, Monti S, O'Connor CM, Kalsheker N: The SERPINE2 gene and chronic obstructive pulmonary disease.Am J Hum Genet 2006, 79(1):184-6; author reply 186-7.         125.   Scott RW, Bergman BL, Bajpai A, Hersh RT, Rodriguez H, Jones BN, Barreda C, Watts S, Baker JB: Protease nexin. Properties and a modified purification procedure.J Biol Chem 1985, 260(11):7029-7034.         126.   Baker JB, Low DA, Simmer RL, Cunningham DD: Protease-nexin: a cellular component that links thrombin and plasminogen activator and mediates their binding to cells.Cell 1980, 21(1):37-45.         127.   Ashitani J, Mukae H, Arimura Y, Matsukura S: Elevated plasma procoagulant and fibrinolytic markers in patients with chronic obstructive pulmonary disease.Intern Med 2002, 41(3):181-185.         128.   Guerassimov A, Hoshino Y, Takubo Y, Turcotte A, Yamamoto M, Ghezzo H, Triantafillopoulos A, Whittaker K, Hoidal JR, Cosio MG: The development of emphysema in cigarette smoke-exposed mice is strain dependent.Am J Respir Crit Care Med 2004, 170(9):974-980.         129.   Judson R, Salisbury B, Schneider J, Windemuth A, Stephens JC: How many SNPs does a genome-wide haplotype map require?Pharmacogenomics 2002, 3(3):379-391.         130.   SAS Genetics [http://www.sas.com/industry/pharma/genetics/]         131.   Haplo.stats [http://cran.r-project.org/doc/packages/haplo.stats.pdf]         132.   Entrez SNP [http://www.ncbi.nlm.nih.gov/projects/SNP/]         133.   The Human Gene Mutation Database [http://archive.uwcm.ac.uk/uwcm/mg/hgmd0.html]         134.   Entrez Gene [http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene]